China: World's Largest MSH Market
TCM kidney-yang/shenkui framework meeting modern PDE5 and TRT
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Mixed: NMPA-approved PDE5 drugs sold alongside unregulated TCM tonics and large counterfeit market
Reference only. Not medical advice.
What can go wrong
The dominant risks are counterfeit and adulterated products. China is repeatedly identified as a major source of counterfeit PDE5 tablets sold globally, which may contain wrong doses, no active drug, or contaminants. 'Herbal' aphrodisiacs spiked with hidden PDE5 inhibitors pose nitrate-interaction danger to unaware users with cardiac disease. Animal tonics raise conservation/legal issues (seahorse and some deer products are CITES-listed) and zoonotic/contaminant concerns.
This is something to take to a clinician. The Atlas can tell you what is known about china: world's largest msh market in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
China is the largest single national market for both erectile-dysfunction drugs and traditional male tonics. Sexual function is culturally framed through Traditional Chinese Medicine concepts of shen (kidney) essence, with 'kidney-yang deficiency' (shen-yang xu) and the culture-bound anxiety syndrome shenkui ('kidney depletion,' tied to fear of semen/jing loss) shaping how men describe and seek help. Modern PDE5 inhibitors arrived and exploded: domestic sildenafil (Baiyunshan's 'Jinge', approved 2014) broke Pfizer's monopoly, and tadalafil/sildenafil generics now dominate. The market is shadowed by an enormous counterfeit-drug and grey-market online-pharmacy problem and by a CITES-relevant trade in animal tonics (deer antler/velvet, seahorse, pilose antler).
Where a two-thousand-year-old kidney-essence framework runs in parallel with the planet's biggest sildenafil market.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Two parallel logics operate. The biomedical one is conventional: PDE5 inhibitors block cGMP breakdown to sustain erection. The TCM one is humoral-energetic: sexual vigor is governed by kidney (shen) yang and stored jing essence; tonics are chosen to 'warm the kidney and reinforce yang' (wen shen zhuang yang) rather than to act on a defined receptor. These frameworks are not interchangeable, and most TCM virility claims lack RCT support; some marketed 'herbal' products have been found spiked with undeclared sildenafil/tadalafil.
What people get wrong
Often saidDeer antler velvet and seahorse 'restore kidney yang' and cure ED
ActuallyThese are traditional tonics without rigorous clinical evidence for erectile function; demand also drives conservation harm. Marketed claims should not be read as proven efficacy.
Often saidTCM 'herbal Viagra' is drug-free and therefore safe
ActuallyMultiple Chinese-origin 'herbal' sexual products have been found adulterated with undeclared sildenafil/tadalafil analogues, creating hidden cardiac risk.
Who profits, and who pushes back
Cochrane / systematic reviewers
Reviews of Chinese herbal medicine for ED generally find low-quality trials and insufficient evidence to confirm efficacy, urging better-controlled studies.
Drug regulators (incl. FDA/NMPA actions)
Repeatedly find 'herbal' or 'natural' virility products spiked with undeclared sildenafil/tadalafil analogues, posing hidden interaction and dosing risks.
Conservation bodies (CITES/TRAFFIC)
Document that demand for animal tonics such as seahorse and deer products drives unsustainable and partly illegal trade in protected species.
How we got here
Male sexual vitality has been theorized in Chinese medicine for over two millennia, with the Huangdi Neijing (Yellow Emperor's Classic) framing kidney essence as the root of reproduction and aging. Daoist 'bedchamber arts' (fangzhongshu) emphasized conserving jing. The shenkui anxiety syndrome, somatic complaints attributed to semen loss, was described in 20th-century Chinese psychiatry and entered cross-cultural psychiatry literature alongside its analogues (India's dhat). Viagra ('Wei Ge', literally 'mighty brother') entered China around 2000; Pfizer's Chinese patent expired in 2014, opening the floodgates to domestic generics.
- ~200 BCEHuangdi Neijing codifies kidney-essence theory of reproduction
- 2000Viagra ('Wei Ge') launched in China
- 2014Pfizer Chinese Viagra patent expires; Baiyunshan 'Jinge' sildenafil approved
- 2010sExplosive growth of online and grey-market PDE5 sales; counterfeit problem scales globally
- 2020sTadalafil/sildenafil generics dominate; TCM tonic e-commerce thrives in parallel
Set against the alternatives
China is distinctive in running two large parallel markets at once. On one track, biomedical ED care exploded after domestic sildenafil ('Jinge', 2014) broke Pfizer's patent monopoly and drove generic-led price competition, making PDE5 inhibitors widely affordable. On the other, a deep TCM tradition frames sexual vigor through kidney-yang and jing conservation, sustaining a vast tonic economy that has little RCT support and overlaps with counterfeiting and protected-species trade. Unlike Western markets where 'alternative' virility products are a fringe, in China the traditional framework is mainstream and culturally authoritative, so men frequently combine tonics with modern drugs rather than choosing between them.
| Dimension | TCM kidney-yang approach | Western biomedical approach | Note |
|---|---|---|---|
| Model of cause | Kidney (shen) yang / jing depletion | Vascular, neural, endocrine | Different ontologies |
| Typical intervention | Warming tonics, animal/herbal | PDE5 inhibitors, TRT | Often used in parallel |
| Evidence base | Mostly traditional, few RCTs | RCT-supported for PDE5 | Quality gap |
| Target | Whole-body 'vigor' balance | Specific receptor/pathway | Holistic vs targeted |
| Key risk | Adulteration, CITES species | Standard drug side effects | Grey-market exposure |
What we do not know
- How much of China's TCM virility market overlaps with hidden PDE5 adulteration?
- Will domestic generic dominance further shrink branded Viagra share?
- Can conservation enforcement curb seahorse/deer demand without driving it underground?
What could change
Integration / standardization of TCMEfforts to subject kidney-tonic formulas to modern trials and quality control.Crackdown on counterfeit and spiked productsRegulatory and e-commerce enforcement against fake and adulterated 'herbal' pills.Online and grey-market telehealth growthDigital pharmacies expanding access while complicating safety oversight.Sustainable substitutes for animal tonicsFarmed or synthetic alternatives explored amid conservation pressure on wild species.
Legal status
Access is bimodal: NMPA-approved PDE5 generics are cheap and easy to obtain (pharmacies and e-commerce), while a vast informal online and TCM-tonic channel sells unregulated and sometimes counterfeit products. Help-seeking is still shaped by stigma and by the cultural preference to frame complaints as 'kidney deficiency' fatigue rather than 'erectile dysfunction'.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
At a glance
- Domestic sildenafil brand
- 'Jinge' (Baiyunshan/Guangzhou Pharma), approved 2014
- Cultural framework
- TCM kidney-yang (shen) essence; jing (semen/essence) conservation
- Culture-bound syndrome
- Shenkui, anxiety over kidney/semen depletion
- Animal tonic trade
- Deer antler velvet, seahorse (Hippocampus), pilose antler
- Counterfeit exposure
- Among the world's largest sources of fake sildenafil/tadalafil
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about China: World's Largest MSH Market. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.